Market share is now 13.7% heading in the short term to 14 %.With cvs caremark making axiron their only supplier reimbursable the market share should grow very quickly.It cant be very long before eli lilly launch in australia and canada (i think this month).
- Forums
- ASX - By Stock
- ims testosterone data/last week
ACR
acrux limited
Add to My Watchlist
5.56%
!
1.7¢

Market share is now 13.7% heading in the short term to 14 %.With...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $6.931M |
Open | High | Low | Value | Volume |
1.8¢ | 1.9¢ | 1.7¢ | $8.809K | 495.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 266679 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 252359 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 266679 | 0.017 |
1 | 218000 | 0.016 |
2 | 266732 | 0.015 |
1 | 70000 | 0.014 |
2 | 397000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 252359 | 2 |
0.019 | 677115 | 3 |
0.020 | 670000 | 3 |
0.021 | 203466 | 1 |
0.022 | 118000 | 2 |
Last trade - 14.49pm 24/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |